COVID-19: Infected Patient Study

This study is for NON-HOSPITALIZED COVID-19 infected patients. The study is single infusion of monoclonal antibody (2 doses) vs Placebo as investigational treatment. Patients will be randomized 1:1:1.

Summary Inclusions for the study are:

• Age 18 years and over
• Covid PCR Positive (on-site testing can also confirm within 45 min)
• One more more of SOB, cough or fever
• COVID Symptoms for less than 7 days
• Able to consent

Summary Exclusions for the study are:

• Hospital admission for COVID
• IVIG infusion in past 3 months
• Treatment with Remdesivir
• Pregnant/Breastfeeding